Xaira Therapeutics Revenue and Competitors

Location

$1B

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Xaira Therapeutics's estimated annual revenue is currently $15.5M per year.(i)
  • Xaira Therapeutics's estimated revenue per employee is $155,000
  • Xaira Therapeutics's total funding is $1B.
  • Xaira Therapeutics's current valuation is $2.1B. (April 2024)

Employee Data

  • Xaira Therapeutics has 100 Employees.(i)
  • Xaira Therapeutics grew their employee count by 1011% last year.

Xaira Therapeutics's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Co-FounderReveal Email/Phone
4
Co-FounderReveal Email/Phone
5
Co-FounderReveal Email/Phone
6
Interim CFO & TreasurerReveal Email/Phone
7
Chief People OfficerReveal Email/Phone
8
Chief Technology OfficerReveal Email/Phone
9
Chief Medical OfficerReveal Email/Phone
10
SVPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Xaira Therapeutics?

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.

keywords:N/A

$1B

Total Funding

100

Number of Employees

$15.5M

Revenue (est)

1011%

Employee Growth %

$2.1B

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.5M100-5%N/A
#2
$21M1000%N/A
#3
$12M100-16%N/A
#4
$21.2M101110%N/A
#5
$25.4M101-10%$60.9M